卡尔帕因抑制可保护肌纤维完整性,并防止瓦德塔尼布诱导的心脏功能障碍
Fang Ji1, Jie Huang1, Jie Yan1
1Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Department of Cardiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, China.
概括
范德特尼布通过通过卡尔激活降解体蛋白质引起心脏功能障碍,而不是问题. 抑制calpain可能会在TKI治疗期间保护心脏.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学 是一个学科.
背景情况:
- 范德特尼布是一种多向的氨酸激酶抑制剂 (TKI),可以治疗甲状腺髓癌,但会引起心脏毒性.
- TKI诱导心脏毒性的机制,特别是激发-收缩解,尚未完全理解.
研究的目的:
- 调查范德坦尼布对心脏收缩能力的影响,重点关注肉蛋白质降解.
- 确定用于逆转肌纤维纤维降解的分子标.
主要方法:
- 在模型系统中慢性vandetanib治疗.
- 评估心肌收缩功能,肌纤维蛋白组织和处理.
- 对calpain表达和活动的分析.
- 卡尔帕因抑制和淘汰/过度表达研究.
主要成果:
- 范德特尼布降低了收缩功能,并破坏了心脏的热素组织,导致cTnT和MYOM1.1的显著损失.
- 处理蛋白仍然不受影响,这表明功能障碍不是由驱动的.
- 卡尔巴因上调和过度激活介导的体蛋白质降解.
- 卡尔帕因抑制部分恢复了收缩蛋白和肌纤维结构.
结论:
- 范德坦提尼布诱导的心脏毒性涉及卡尔巴因依赖的sarcomeric蛋白质降解,独立于调节失调.
- 在TKI治疗期间,sarcomere稳定性对心脏功能至关重要.
- 卡尔帕因抑制是针对TKI心脏毒性进行心脏保护的潜在治疗策略.
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.7K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Actin Filament Depolymerization
4.1K
Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
In F-actin, the ADF/cofilin proteins...
4.1K
Skeletal Muscle Relaxants: Adverse Effects
962
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
962
Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Antihypertensive Drugs: Action of Calcium Channel Blockers
2.0K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.0K


